Estrogen Replacement in Anorexia Nervosa

Status Terminated

Clinical Trial Summary

The present study is a placebo-controlled randomised study on the effects of estrogen replacement upon AN-associated psychopathology, several neurocognitive domains and appetite-regulating circuits in female patients with AN.

The investigators aim at assessing peripheral concentrations of neuroendocrinological components of the Hypothalamus-Pituitary-Gonadal (HPG) and Hypothalamus-Pituitary-Adrenal (HPA) axis, as well as appetite-regulating hormones in AN and to examine associations with AN-associated psychopathology and neurocognitive performances before (baseline), during and after inpatient psychotherapy of female patients receiving concomitant treatment with estrogens (vs. placebo).

Clinical Trial Description

While there is broad knowledge on the disruption of appetite regulation, neurocognitive deficits in AN patients, the impact of cortisol on neurocognitive performances in patients with AN and the effects of estrogen on neurocognitive features in healthy subjects, up to now, no study has implemented estrogen replacement in AN patients, in order to examine ist effects upon AN-associated psychopathology, neurocognition and peptides regulating appetite. Thus, this is the first study of its kind.

Primary target: Assessment of the impact of sexual hormone replacement using an estrogen-progestin-combination as add-on to psychotherapy upon neurocognitive performance in patients suffering from anorexia nervosa by means of a neuropsychological test battery consisting of a test of verbal intelligence, the Trail making test A and B, a Go/No-go paradigm and the Wisconsin Card Sorting Test.

Secondary targets:

- Examination of safety and tolerability of sexual hormone replacement using an estrogen-progestin-combination in patients with anorexia nervosa.

- Assessment of the impact of the sexual hormone replacement upon psychopathology in patients with anorexia nervosa by means of the Eating Disorder Examination Questionnaire (EDE-Q) and the Eating Disorder Inventory-2 (EDI-2).

- Assessment of the impact of substitution upon anxiety (STAI)

- Assessment of the impact on cortisol levels

- Assessment of the impact on appetite-regulating plasma peptides

- Assessment of the impact on the prescription of antidepressants ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03172533
Study type	Interventional
Source	University of Erlangen-Nürnberg Medical School
Contact
Status	Terminated
Phase	Phase 2
Start date	March 15, 2016
Completion date	January 15, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05531604` - Appetitive Conditioning in Anorexia Nervosa
Enrolling by invitation	`NCT04174703` - Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing	N/A
Active, not recruiting	`NCT04883554` - Impact of an Olfactory Sensory Therapeutic Group for Adolescent Patients With Restrictive Anorexia Nervosa , Pilot Study	N/A
Recruiting	`NCT04213820` - TMS and Body Image Treatment for Anorexia Nervosa	N/A
Completed	`NCT03414112` - The Impact of Oxytocin on the Neurobiology of Anorexia Nervosa	Early Phase 1
Recruiting	`NCT06144905` - Norwegian Microbiota Study in Anorexia Nervosa
Recruiting	`NCT05803707` - Home-based Adapted Physical Activity in Anorexia Nervosa: a Feasibility Pilot Study	N/A
Recruiting	`NCT05682417` - Impact of Body Schema Distortion on Remission and Weight Regain in Anorexia Nervosa	N/A
Not yet recruiting	`NCT06380257` - Anorexia Nervosa and Brain in Adolescence
Not yet recruiting	`NCT04804800` - Virtual Reality Place in the Management of Body Dysmorphia Disorders in Anorexia Nervosa	N/A
Not yet recruiting	`NCT03600610` - Evaluation of CARdiac Abnormalities by Echocardiography and MRI in Malnourished Patients Suffering From Anorexia Nervosa	N/A
Completed	`NCT02745067` - Effectiveness of Enhanced Cognitive Behavioral Therapy (CBT-E) in the Treatment of Anorexia Nervosa	N/A
Completed	`NCT02382055` - Changing Habits in Anorexia Nervosa: Novel Treatment Development	N/A
Completed	`NCT03075371` - Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa	N/A
Terminated	`NCT02240797` - Kappa Opioid Receptor Imaging in Anorexia	N/A
Unknown status	`NCT01761942` - Fatty Acids Omega -3 Diet Supplementation Efficiency and Safety Evaluation in Anorexia Nervosa	Phase 2
Completed	`NCT03144986` - Insula-coil Deep TMS for Treatment Resistant Anorexia Nervosa	N/A
Completed	`NCT02551445` - A fMRI Pilot Study of the Effects of Meal-support in Eating Disorders.	N/A
Completed	`NCT01579682` - Adaptive Family Treatment for Adolescent Anorexia Nervosa	N/A
Completed	`NCT00946816` - The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Estrogen Replacement in Anorexia Nervosa — HOSAN

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms